GCM
FLNA

Gallacher Capital Management’s Filana Therapeutics FLNA Stock Holding History

Gallacher Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-64,972
Closed -$110K – 336
2026
Q1 		$110K Sell
64,972
-3
-0% -$6 0.04% 298
2025
Q4 		$129K Hold
64,975
– – 0.05% 293
2025
Q3 		$189K Hold
64,975
– – 0.07% 296
2025
Q2 		$118K Sell
64,975
-4,685
-7% -$8.34K 0.05% 281
2025
Q1 		$104K Sell
69,660
-83,286
-54% -$210K 0.05% 272
2024
Q4 		$361K Sell
152,946
-427,096
-74% -$7.5M 0.18% 156
2024
Q3 		$17.1M Sell
580,042
-2,446
-0.4% -$56.3K 7.83% 2
2024
Q2 		$7.19M Sell
582,488
-2,893
-0.5% -$61K 3.79% 2
2024
Q1 		$11.9M Buy
585,381
+3,775
+0.6% +$87K 6.03% 2
2023
Q4 		$13.1M Buy
581,606
+3,782
+0.7% +$79.9K 7.3% 2
2023
Q3 		$9.61M Sell
577,824
-5,468
-0.9% -$108K 6% 2
2023
Q2 		$14.3M Sell
583,292
-4,627
-0.8% -$111K 8.26% 2
2023
Q1 		$14.2M Sell
587,919
-614
-0.1% -$17K 8.51% 2
2022
Q4 		$17.4M Buy
+588,533
New +$21.2M 10.52% 2

Other funds holding FLNA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Gallacher Capital Management's FLNA Position: Q2 2026 in Review

Gallacher Capital Management sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 64,972 shares — an estimated $110K sold.

Gallacher Capital Management first reported a position in FLNA in Q4 2022 and held it in 14 quarters. The position peaked at $17.4M in Q4 2022. 15 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Gallacher Capital Management reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Gallacher Capital Management sold 64,972 Filana Therapeutics shares in Q2 2026, an estimated $110K.
  • Gallacher Capital Management first reported a position in Filana Therapeutics in Q4 2022 and held it in 14 quarters.
  • Gallacher Capital Management's Filana Therapeutics position peaked at $17.4M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.